Doping in sport primarily involves the misuse and abuse of new chemical entities in development and of commercially available medicines.

Doping affects the fairness of sport competitions by illegally enhancing athletic performance, causes potentially harmful health effects and violates the spirit of sport. Not only the elite athlete population is affected, but also larger groups of amateur and young athletes, as well as people aiming at improving their physical appearance. That’s why today, doping is declared a public health issue by national and international authorities.

The international fight against doping in sport produces tangible/concrete results throughcooperation between multiple stakeholders. The results of several collaborations between the innovative pharmaceutical industry and anti-doping authorities clearly demonstrate the mutual benefit in developing anti-doping capacity for newly developed and commercially available medicines thus limiting access to drug abuse in sport and reducing the health risk of exposed populations.